Proteinea

PROSION

This deep-tech company develops small molecule inhibitors to target undruggable proteins for patients with cancer and other serious diseases.

AI Proteins

This deep-tech company designs engineered miniprotein biologics for patients and pharmaceutical partners using artificial intelligence and synthetic biology.

A-Alpha Bio

This deep-tech company provides protein interaction data and predictive models to pharmaceutical firms for the discovery and engineering of new medicines.

MendelFOLD

This company develops computational protein modelling tools to help pharmaceutical teams and researchers identify drug binding sites and design new medical treatments.

SymphoRNA

This deep-tech company develops multi-RNA combination medicines to treat complex diseases such as fibrosis and heart failure for the pharmaceutical and healthcare sectors.

Tubulis

This deep-tech company develops antibody-drug conjugates to treat patients with solid tumours.

Mähmi Bio

This company develops hypoallergenic food proteins using artificial intelligence and fermentation for food and medical nutrition manufacturers.

Granza Bio

This deep-tech company develops attack particle medicines to treat patients with cancer, autoimmune diseases and infections.